Chronochemotherapy: L 1210 leukemia and beyond

F. Halberg, W. Nelson, Germaine G Cornelissen-Guillaume, E. Haus, L. E. Scheving, R. A. Good

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


In cancer and other therapeutic research, an interpretation of median survival times can and should take cure into account. With this qualification, an analysis of recently published data provides further statistically evidence in favor of cancer chronotherapy as compared to homesostatic therapy.

Original languageEnglish (US)
Pages (from-to)203-210
Number of pages8
Issue number3
StatePublished - 1979


Dive into the research topics of 'Chronochemotherapy: L 1210 leukemia and beyond'. Together they form a unique fingerprint.

Cite this